Trials / Recruiting
RecruitingNCT06426355
The Effeciency of NMN in Improving IVF/ICSI-ET Pregnancy Outcomes in Patients With DOR
The Effeciency of Nicotinamide Mononucleotide (NMN) in Improving IVF/ICSI-ET Pregnancy Outcomes in Patients With Decreased Ovarian Reserve（DOR): a Randomized Double-blind Placebo Control Clinical Trail
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 200 (estimated)
- Sponsor
- Peking University Third Hospital · Academic / Other
- Sex
- Female
- Age
- 20 Years – 40 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the study is to understand the effect of nicotinamide mononucleotide (NMN) on patients with diminished ovarian reserve and the outcomes of IVF/ICSI-ET.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | NMN | NMN capsules (total of 600mg/day) for 2-5 months |
| OTHER | Placebo | NMN-free placebo capsules for 2-5 months |
Timeline
- Start date
- 2023-10-01
- Primary completion
- 2026-02-01
- Completion
- 2027-02-01
- First posted
- 2024-05-23
- Last updated
- 2024-05-23
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06426355. Inclusion in this directory is not an endorsement.